Benjamin Wolozin on A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
COMMENT This study suggests a novel mechanism by which NSAIDs might be protective in AD, and a potentially novel and selective mechanism for lowering Ab42 production. This is important because Ab42 is thought to be a critical factor initiating Ab aggregation.-- B